Lincomycin HCL is a white or almost white crystalline powder, chemically classified as Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside hydrochloride.
Molecular Composition: The molecule consists of an amino acid (trans-L-4-n-propylhygric acid) linked to an amino sugar (celestosamine). This complex structure is produced through a precise fermentation process.
The HCL Salt Factor: The hydrochloride salt form is the industry standard for several reasons. It provides superior water solubility (approximately 500 mg/mL), high stability in dry form, and excellent compatibility with various pharmaceutical excipients. In veterinary medicine, where "water-medication" is the primary route for treating large flocks or herds, the high solubility of the HCL salt ensures a clear, sediment-free solution that won't clog automatic drinking systems.
Stability Profile: Lincomycin HCL is remarkably stable across a wide pH range (2.0 to 9.0), which allows it to remain potent throughout the digestive tract and within various tissue environments.
Lincomycin HCL is primarily a bacteriostatic agent, though it can exhibit bactericidal activity at higher concentrations or against highly sensitive organisms.
Targeting the 50S Subunit: The molecule enters the bacterial cell and binds specifically to the 23S fraction of the 50S ribosomal subunit.
Inhibiting Peptidyl Transferase: By binding to this site, it prevents the enzyme peptidyl transferase from catalyzing the formation of peptide bonds. This effectively stops the translocation process, where the tRNA moves from the A-site to the P-site.
Cross-Resistance Awareness: Because Lincomycin binds to a site overlapping with macrolides (like Erythromycin) and streptogramins, there is a risk of "MLS" (Macrolide-Lincosamide-Streptogramin) cross-resistance. However, Lincomycin often remains effective against pathogens that have developed resistance to other antibiotic classes through different mechanisms.
The therapeutic "sweet spot" for Lincomycin HCL is its activity against Gram-positive cocci and obligate anaerobes.
Aerobic Gram-Positives: Highly effective against Staphylococcus spp. (including many penicillin-resistant strains), Streptococcus spp., and Diplococcus.
Anaerobic Pathogens: It is a front-line choice for Clostridium perfringens, Fusobacterium, and Bacteroides spp.
Mycoplasma: One of Lincomycin’s most valued traits in veterinary medicine is its potent activity against various Mycoplasma species, which are major drivers of respiratory disease in pigs and poultry.
Lincomycin HCL is arguably most famous for its role in swine health. It is the "gold standard" for treating:
Swine Dysentery: Caused by Brachyspira hyodysenteriae. Lincomycin is one of the few agents that can penetrate the colonic mucosa effectively enough to eliminate the pathogen.
Porcine Proliferative Enteropathy (Ileitis): Caused by Lawsonia intracellularis.
Mycoplasmal Pneumonia: It significantly reduces lung lesions and improves growth rates in finishing pigs.
In poultry, the primary use of Lincomycin HCL is the control of Necrotic Enteritis caused by Clostridium perfringens. By maintaining gut health, Lincomycin ensures that birds reach their target weight without the feed-conversion losses associated with subclinical intestinal infections.
In sheep and cattle, Lincomycin is frequently used to treat Foot Rot (caused by Dichelobacter nodosus and Fusobacterium necrophorum). Its ability to penetrate soft tissue and bone makes it highly effective for localized infections of the extremities.
For companion animals, Lincomycin is often used for deep-seated pyodermas (skin infections), abscesses, and osteomyelitis (bone infections). Its unique ability to accumulate in bone tissue at levels equal to or exceeding serum levels makes it superior to many other antibiotics for orthopedic infections.
One cannot discuss Lincomycin HCL without mentioning its synergistic partnership with Spectinomycin. The "Linco-Spectin" combination (usually in a 1:1 or 1:2 ratio) is one of the most successful antibiotic pairings in history.
Broadened Spectrum: While Lincomycin targets Gram-positives and anaerobes, Spectinomycin covers Gram-negative bacteria like E. coli and Salmonella.
Enhanced Mycoplasma Activity: Together, they exhibit a synergistic effect against Mycoplasma, providing a "one-two punch" that is more effective than either drug used alone.
Manufacturing Lincomycin HCL requires a high level of expertise in industrial fermentation. When evaluating a supplier, technical buyers must look at the following markers of quality:
Lincomycin B Content: During fermentation, a related substance called Lincomycin B is naturally produced. While it has some activity, high levels of Lincomycin B are considered an impurity and can reduce the overall potency of the API. According to the European Pharmacopoeia (EP) and USP, Lincomycin B must be strictly limited (usually <5%).
Specific Optical Rotation: This is the most accurate way to verify the identity and purity of the D-isomer. The standard range is typically +135° to +149°.
pH and Clarity: When dissolved in water, the solution should be clear and colorless, with a pH between 3.0 and 5.5. A yellow tint or turbidity indicates degradation or the presence of fermentation residues.
Endotoxin Control: For injectable grades, the bacterial endotoxin level must be extremely low to prevent systemic shock in the animal.
Crystallinity and Particle Size: Consistent particle size is essential for the formulation of uniform premixes and the stability of injectable suspensions.
While Lincomycin is highly effective, it has a specific contraindication that every veterinarian must know: It must NEVER be administered to horses, rabbits, guinea pigs, or hamsters. In these species, Lincomycin (and other lincosamides) causes a severe, often fatal, necrotizing enterocolitis by disrupting the sensitive balance of their gastrointestinal microflora.
Arshine Vet, the core veterinary division of the Arshine Group, is a premier global service provider dedicated to the supply of high-purity veterinary APIs, including Lincomycin HCL.
With a presence in over 100 countries and regions, Arshine Vet has built a "bridge of trust" between high-end manufacturing and global animal husbandry. We do not just sell chemicals; we provide a complete quality assurance ecosystem. Our Lincomycin HCL is sourced from top-tier, GMP-certified fermentation plants that employ the latest strain-improvement technologies.
The Arshine Advantage:
Rigorous Auditing: We conduct thorough on-site audits of our manufacturers to ensure that every step—from fermentation to final crystallization—meets international standards (CEP/USP/BP).
Independent Testing: Every batch of Lincomycin HCL is re-tested in our internal laboratory for potency, Lincomycin B levels, and moisture content.
Registration Support: Our professional regulatory team assists clients in preparing Drug Master Files (DMF) and technical dossiers for local veterinary drug registrations.
Global Logistics: We offer optimized shipping solutions, ensuring that your raw materials arrive on time and in perfect condition, regardless of your location.
At Arshine Vet, we are committed to the philosophy of "Better Quality, Better Health." By providing superior antibiotics like Lincomycin HCL, we help farmers protect their livestock and ensure the safety of the global food chain.
For technical inquiries, price quotations, or to request a Certificate of Analysis (COA), please contact our expert team:
Add: Block 14, No.100, Luyun Road, Changsha 410205, Hunan, China.
Email: info@arshinevet.com
WeChat: +8618874001228
WhatsApp: +8615697311407
Tel: 86-731-82294958
Product Link:https://arshinevet.com/product-detail/lincomycin-hcl-ep-usp-bp
Add: Block 14, No.100, Luyun Road, Changsha 410205, Hunan, China.
Email: info@arshinevet.com
WeChat: +8618874001228
WhatsApp: +8615697311407
Tel：86-731-82294958
EN
ES
FR
AR